The nuetraphase product is a better product than Oculus one. More effective and stable and safe to use in wound care. Bleach can not be used in wound care. Galderma has been slow to start up phase 2b but this timeline is the norm with big pharma. Phase 2a was very succesful and galderma has committed to 62 million in milestone payments. The money raised last summer was so that NBY could proced on there own with the viral conjunctivitis study then partner with big pharma at more favorable terms. The alcon study was exciting for the most severe form of conjunctivitis. Why would nby raise more money and go ahead with this next study if the alcon study was a failure? The chinese deal exposes their product to a 1000 man sales force. Why not do this?
As most of you know there is a big story brewing here. The bigger piece of this story was not even mentioned by this individual.
This uninformed and unprofessional opinion was just timed after a huge run up. That's all.
I have always laughed at the guys that talk "MM's"
This is the NASDAQ and not the NYSE first of all. Second, in this day of hedge funds and technology you have NO IDEA what is about ready to hit you between the eyes. Tell the guy that gets a margin call that the price does not matter. It's all that matters.
Good luck and watch this close!
New high as we speak. It is no coincidence i was on here yesterday refuting to shorts noise. They will all start wanting a better cover price just like the longs at 120. Textbook.
Been doing this too long to fall flat...
GOOG is going to put Facebook out of business with its GOOG+. Right!
There is no such product in dev. and Micros does not have enough reach.